Cargando…
Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials
BACKGROUND: Thromboembolic and bleeding events after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are major public concerns leading to vaccine hesitancy. Due to low incidence, an individual randomized controlled trial (RCT) is underpowered to determine whether SAR...
Autores principales: | Uaprasert, Noppacharn, Panrong, Krissana, Rojnuckarin, Ponlapat, Chiasakul, Thita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590131/ https://www.ncbi.nlm.nih.gov/pubmed/34774069 http://dx.doi.org/10.1186/s12959-021-00340-4 |
Ejemplares similares
-
Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis
por: Uaprasert, Noppacharn, et al.
Publicado: (2022) -
Anticoagulation and In-Hospital Mortality From Coronavirus Disease
2019: A Systematic Review and Meta-Analysis
por: Moonla, Chatphatai, et al.
Publicado: (2021) -
Systemic Coagulopathy in Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
por: Uaprasert, Noppacharn, et al.
Publicado: (2021) -
Heparin-induced thrombocytopenia in patients with COVID-19: a systematic review and meta-analysis
por: Uaprasert, Noppacharn, et al.
Publicado: (2021) -
Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies
por: Uaprasert, Noppacharn, et al.
Publicado: (2021)